Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach

被引:45
作者
Ding, Li [1 ]
Mo, Allen [1 ,2 ]
Jutivorakool, Kamonwan [1 ]
Pancholi, Minjal [1 ]
Holland, Steven M. [1 ]
Browne, Sarah K. [1 ]
机构
[1] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA
[2] Colgate Univ, Hamilton, NY 13346 USA
关键词
Interferon gamma; luminex; thymoma; pulmonary alveolar proteinosis; immunodeficiency; PEMPHIGUS-VULGARIS; RITUXIMAB; DISEASE; ASSAY; IGG;
D O I
10.1007/s10875-011-9621-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Anticytokine autoantibodies cause numerous human diseases, ranging from pure red cell aplasia to acquired immunodeficiencies. Rapid, simple, and affordable detection and monitoring of these antibodies is essential. We sought to develop a standardizable assay that is rapid, sensitive, and specific and able to simultaneously detect multiple anticytokine autoantibodies in small volumes (<10 mu l). Methods We conjugated purified human cytokines to commercially available fluorescently labeled microspheres and tested them against sera from well-characterized subjects with at least one high-titer, disease-associated anticytokine autoantibody. Results Cytokine-conjugated microspheres efficiently and rapidly determined plasma concentration and IgG subclass of anticytokine autoantibodies in single or multiplex formats. Conclusion This particle-based multiplex assay can reproducibly characterize anticytokine autoantibodies. This efficient and inexpensive approach to diagnosing and monitoring anticytokine autoantibodies has clinical applications.
引用
收藏
页码:238 / 245
页数:8
相关论文
共 17 条
[1]   Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: A case report [J].
Behler C.M. ;
Terrault N.A. ;
Etzell J.E. ;
Damon L.E. .
Journal of Medical Case Reports, 3 (1)
[2]   CORRELATION OF SUBCLASSES OF IGG WITH DISEASE-ACTIVITY IN PEMPHIGUS-VULGARIS [J].
BHOL, K ;
MOHIMEN, A ;
AHMED, AR .
DERMATOLOGY, 1994, 189 :85-89
[3]   CORRELATION OF PEPTIDE SPECIFICITY AND IGG SUBCLASS WITH PATHOGENIC AND NONPATHOGENIC AUTOANTIBODIES IN PEMPHIGUS-VULGARIS - A MODEL FOR AUTOIMMUNITY [J].
BHOL, K ;
NATARAJAN, K ;
NAGARWALLA, N ;
MOHIMEN, A ;
AOKI, V ;
AHMED, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :5239-5243
[4]   Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test [J].
Bonfield, TL ;
John, N ;
Barna, BP ;
Kavuru, MS ;
Thomassen, MJ ;
Yen-Lieberman, B .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (07) :821-824
[5]   Rituximab therapy in autoimmune pulmonary alveolar proteinosis [J].
Borie, R. ;
Debray, M-P. ;
Laine, C. ;
Aubier, M. ;
Crestani, B. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) :1503-1506
[6]   Immunodeficiency secondary to anticytokine autoantibodies [J].
Browne, Sarah K. ;
Holland, Steven M. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 10 (06) :534-541
[7]   Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia [J].
Burbelo, Peter D. ;
Browne, Sarah K. ;
Sampaio, Elizabeth P. ;
Giaccone, Giuseppe ;
Zaman, Rifat ;
Kristosturyan, Ervand ;
Rajan, Arun ;
Ding, Li ;
Ching, Kathryn H. ;
Berman, Arlene ;
Oliveira, Joao B. ;
Hsu, Amy P. ;
Klimavicz, Caitlin M. ;
Iadarola, Michael J. ;
Holland, Steven M. .
BLOOD, 2010, 116 (23) :4848-4858
[8]   A multiplex microsphere bead assay for comparative RNA expression analysis using flow cytometry [J].
Fuja, T ;
Hou, S ;
Bryant, P .
JOURNAL OF BIOTECHNOLOGY, 2004, 108 (03) :193-205
[9]   An open-label trial of rituximab therapy in pulmonary alveolar proteinosis [J].
Kavuru, M. S. ;
Malur, A. ;
Marshall, I. ;
Barna, B. P. ;
Meziane, M. ;
Huizar, I. ;
Dalrymple, H. ;
Karnekar, R. ;
Thomassen, M. J. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (06) :1361-1367
[10]   Rituximab for severe myasthenia gravis - experience from five patients [J].
Lindberg, C. ;
Bokarewa, M. .
ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (04) :225-228